CIBC Asset Management Inc Acquires 23,786 Shares of Tilray Inc (NASDAQ:TLRY)

CIBC Asset Management Inc raised its holdings in Tilray Inc (NASDAQ:TLRYFree Report) by 3.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 672,586 shares of the company’s stock after buying an additional 23,786 shares during the quarter. CIBC Asset Management Inc owned 0.09% of Tilray worth $1,558,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Clear Street Markets LLC acquired a new stake in shares of Tilray in the 3rd quarter valued at $25,000. RPO LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $28,000. Gainplan LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $28,000. International Assets Investment Management LLC boosted its stake in shares of Tilray by 179.0% in the 4th quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock valued at $34,000 after purchasing an additional 9,453 shares in the last quarter. Finally, Cerity Partners LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $35,000. Institutional investors own 9.35% of the company’s stock.

Tilray Price Performance

Tilray stock opened at $1.77 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. Tilray Inc has a 1 year low of $1.50 and a 1 year high of $3.40. The company’s 50-day moving average is $1.98 and its two-hundred day moving average is $1.96.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on TLRY shares. CIBC reduced their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Alliance Global Partners upped their price target on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research report on Friday, April 5th. Finally, Canaccord Genuity Group reduced their price target on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th.

Get Our Latest Analysis on Tilray

About Tilray

(Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

See Also

Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRYFree Report).

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.